GGrantIndex
← Leaderboards

Jetze J Tepe

Michigan State University

$5,195,343
Attributed
$6,290,171
Total exposure
9
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.3M · FY200522
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22

Funding mix

By agency

NIH$6,290,171 · 9

By mechanism

R01$3,670,803 · 3
R21$1,536,568 · 4
R61$698,872 · 1
R33$383,928 · 1

Most similar at Michigan State University

Same institution · by research overlap

Others in their field

Top investigators on “Alzheimer&Apos

Research focus

Alzheimer&AposCellsProteinsPharmaceutical PreparationsMulticatalytic Endopeptidase ComplexDesignMediatingPathogenesisSignal TransductionSmall MoleculeBindingS DiseaseDrug DesignNovel StrategiesNeurodegenerative DisordersNovel Therapeutic InterventionDrug DiscoveryParkinson DiseaseAlpha SynucleinLeadBrainS Disease Related DementiaPreventEffective Therapy

Grant awards (27)

Development of Cellular HTS for 20S Proteasome Enhancers$383,928
R33 · FY2022 · NS · contact PI
Small molecule induced proteolytic destruction of intrinsically disordered proteins$366,910
R01 · FY2022 · AG · contact PI
Overcoming proteasome impairment with small molecules$221,019
R21 · FY2022 · AG · contact PI
Overcoming proteasome impairment with small molecules$167,891
R21 · FY2022 · AG · contact PI
Small molecule induced proteolytic destruction of intrinsically disordered proteins$57,182
R01 · FY2022 · AG · contact PI
Small molecule induced proteolytic destruction of intrinsically disordered proteins$53,583
R01 · FY2022 · AG · contact PI
Small molecule induced proteolytic destruction of intrinsically disordered proteins$34,307
R01 · FY2022 · AG · contact PI
Small molecule induced proteolytic destruction of intrinsically disordered proteins$428,566
R01 · FY2021 · AG · contact PI
Development of cellular HTS for 20S proteasome enhancers$343,015
R61 · FY2021 · NS · contact PI
Multiparameter optimization of new phenothiazines for proteasome activation$220,149
R21 · FY2021 · AG · contact PI
Small molecule induced proteolytic destruction of intrinsically disordered proteins$17,862
R01 · FY2021 · AG · contact PI
Small molecule induced proteolytic destruction of intrinsically disordered proteins$368,746
R01 · FY2020 · AG · contact PI
Development of cellular HTS for 20S proteasome enhancers$355,857
R61 · FY2020 · NS · contact PI
Multiparameter optimization of new phenothiazines for proteasome activation$181,586
R21 · FY2020 · AG · contact PI
Small molecule induced proteolytic destruction of intrinsically disordered proteins$369,612
R01 · FY2019 · AG · contact PI
Non-competitive proteasome inhibitors to treat chronic, drug-resistant tuberculosis$219,058
R21 · FY2017 · AI
Non-competitive proteasome inhibitors to treat chronic, drug-resistant tuberculosis$180,825
R21 · FY2016 · AI
Characterization of non-competitive proteasome binding$156,119
R21 · FY2015 · CA · contact PI
Characterization of non-competitive proteasome binding$189,921
R21 · FY2014 · CA · contact PI
Inhibition of interleukin-6 production for the treatment of multiple myeloma$266,137
R01 · FY2012 · CA · contact PI
Inhibition of interleukin-6 production for the treatment of multiple myeloma$266,740
R01 · FY2011 · CA · contact PI
Inhibition of interleukin-6 production for the treatment of multiple myeloma$275,569
R01 · FY2010 · CA · contact PI
New Methods of Phosphoproteomics$226,805
R01 · FY2008 · GM · contact PI
New Methods of Phosphoproteomics$226,805
R01 · FY2007 · GM · contact PI
New Methods of Phosphoproteomics$233,579
R01 · FY2006 · GM · contact PI
New Methods of Phosphoproteomics$239,200
R01 · FY2005 · GM
New Methods of Phosphoproteomics$239,200
R01 · FY2004 · GM